Similarly, the infiltration of CD8+ T cells into tumors was increased following CCRT in esophageal cancer [66,67,68], and responses of circulating T cells to tumor-associated antigens were enhanced following CCRT to esophageal cancer [69]. The gene discussed is CD8A; the disease is neoplasm.